Anonymous ID: b825e9 Nov. 9, 2020, 10:53 a.m. No.11560492   🗄️.is 🔗kun

>>11559885 (lb)

 

c'mon man, do the digs.

 

the vaccine is still uncertain, read between the lines. all hype without conclusive data or proof, it's bullshit at this point!

 

msm is, as usual, is full of deviant, lying bullshit!

 

expert reaction to Pfizer and BioNTech reporting interim results from phase 3 COVID-19 vaccine trial

November 9, 2020

 

Prof Stephen Evans, Professor of Pharmacoepidemiology, London School of Hygiene & Tropical Medicine, said:

 

“These provisional results look promising and this is a great encouragement for all the vaccines under trial. However, once again we have a press release without detailed data, even on the provisional result, but 90% efficacy is definitely good news, but there is some uncertainty. It is not known whether the efficacy is constant across age groups, and it is results in the elderly that are required for the first use of the vaccine in high risk people.

 

“It seems difficult in the light of an encouraging finding to raise concerns. The fact that the DSMB should release results but also continue the trial recruitment is unprecedented in my experience. It is going to make recruitment more difficult and the ethics of continuing to randomise people to placebo within this trial may be questioned. It may also lead to pressure to vaccinate the placebo group with the Pfizer vaccine. This will mean that the longer term follow-up within the properly randomised trial will become difficult, and it may be the longer term where the true benefit and harm balance will need to be assessed.”

 

“It’s encouraging news, but the process does not seem to have followed usual procedures, and that might leave some concerns.”

 

https://www.sciencemediacentre.org/expert-reaction-to-pfizer-and-biontech-reporting-interim-results-from-phase-3-covid-19-vaccine-trial/